These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26961977)

  • 1. Monoamine Oxidase Inhibition in a Patient With Type 1 Diabetes and Depression.
    Emory H; Mizrahi N
    J Diabetes Sci Technol; 2016 Sep; 10(5):1203-4. PubMed ID: 26961977
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoamine oxidase inhibitors revisited: what you should know.
    Goldberg JF; Thase ME
    J Clin Psychiatry; 2013 Feb; 74(2):189-91. PubMed ID: 23473352
    [No Abstract]   [Full Text] [Related]  

  • 3. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine oxidase inhibitors as treatment for depressed patients with primary degenerative dementia (Alzheimer's disease).
    Jenike MA
    Am J Psychiatry; 1985 Jun; 142(6):763-4. PubMed ID: 4003602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human plasma melatonin is elevated during treatment with the monoamine oxidase inhibitors clorgyline and tranylcypromine but not deprenyl.
    Murphy DL; Tamarkin L; Sunderland T; Garrick NA; Cohen RM
    Psychiatry Res; 1986 Feb; 17(2):119-27. PubMed ID: 3008207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: implications for clinical use.
    Simpson GM; Frederickson E; Palmer R; Pi E; Sloane RB; White K
    Biol Psychiatry; 1985 Jun; 20(6):684-7. PubMed ID: 3922441
    [No Abstract]   [Full Text] [Related]  

  • 7. Bupropion-tranylcypromine combination for treatment-refractory depression.
    Pierre JM; Gitlin MJ
    J Clin Psychiatry; 2000 Jun; 61(6):450-1. PubMed ID: 10901349
    [No Abstract]   [Full Text] [Related]  

  • 8. Translating the evidence on atypical depression into clinical practice.
    Rapaport MH; Thase ME
    J Clin Psychiatry; 2007 Apr; 68(4):e11. PubMed ID: 17474801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranylcypromine plus risperidone for treatment-refractory major depression.
    Stoll AL; Haura G
    J Clin Psychopharmacol; 2000 Aug; 20(4):495-6. PubMed ID: 10917417
    [No Abstract]   [Full Text] [Related]  

  • 10. Classics in Chemical Neuroscience: Selegiline, Isocarboxazid, Phenelzine, and Tranylcypromine.
    Hoffman GR; Olson MG; Schoffstall AM; Estévez RF; Van den Eynde V; Gillman PK; Stabio ME
    ACS Chem Neurosci; 2023 Dec; 14(23):4064-4075. PubMed ID: 37966854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycaemic control by monoamine oxidase inhibition in a patient with type 1 diabetes.
    Emory H; Mizrahi N
    Diab Vasc Dis Res; 2017 Mar; 14(2):163-165. PubMed ID: 27884951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moclobemide and selegeline in the treatment of depression in Parkinson's disease.
    Steur EN; Ballering LA
    J Neurol Neurosurg Psychiatry; 1997 Oct; 63(4):547. PubMed ID: 9343144
    [No Abstract]   [Full Text] [Related]  

  • 13. Transdermal selegiline: the new generation of monoamine oxidase inhibitors.
    Patkar AA; Pae CU; Masand PS
    CNS Spectr; 2006 May; 11(5):363-75. PubMed ID: 16641841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase inhibitors in resistant major depression. A double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressants.
    Nolen WA; Haffmans PM; Bouvy PF; Duivenvoorden HJ
    J Affect Disord; 1993 Jul; 28(3):189-97. PubMed ID: 8408980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with low doses of tranylcypromine resulted in a disappointing remission rate.
    Nolen WA; van den Broek WW; Birkenhäger TK
    Am J Psychiatry; 2007 Mar; 164(3):524; author reply 524. PubMed ID: 17329480
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute exacerbation of depression after discontinuation of monoamine oxidase inhibitor prior to cardiac surgery.
    Abdi S; Fishman SM; Messner E
    Anesth Analg; 1996 Sep; 83(3):656-7. PubMed ID: 8780301
    [No Abstract]   [Full Text] [Related]  

  • 17. Tranylcypromine treatment of major depression.
    Liebowitz MR
    J Clin Psychiatry; 1987 Jul; 48(7):303. PubMed ID: 3597337
    [No Abstract]   [Full Text] [Related]  

  • 18. MAO inhibition as antidepressive mechanism reevaluated. A controlled study with tranylcypromine isomers.
    Beckmann H; Moises HW
    Mod Probl Pharmacopsychiatry; 1983; 19():211-4. PubMed ID: 6865965
    [No Abstract]   [Full Text] [Related]  

  • 19. Moclobemide versus tranylcypromine in the treatment of depression.
    Rossel L; Moll E
    Acta Psychiatr Scand Suppl; 1990; 360():61-2. PubMed ID: 2248075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel transdermal delivery formulation of the monoamine oxidase inhibitor selegiline nearing release for treatment of depression.
    Thase ME
    J Clin Psychiatry; 2006 Apr; 67(4):671-2. PubMed ID: 16669733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.